EXAGEN INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Exagen Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Exagen Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $42.9M, a 11.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.9M +$4.38M +11.3% Dec 31, 2023 10-K 2024-03-18
Q4 2022 $38.6M +$11.4M +42% Dec 31, 2022 10-K 2024-03-18
Q4 2021 $27.2M +$6.56M +31.9% Dec 31, 2021 10-K 2024-03-18
Q4 2020 $20.6M +$3.8M +22.6% Dec 31, 2020 10-K 2023-03-20
Q4 2019 $16.8M -$4.34M -20.5% Dec 31, 2019 10-K 2022-03-22
Q4 2018 $21.1M +$1.21M +6.07% Dec 31, 2018 10-K 2021-03-16
Q4 2017 $19.9M Dec 31, 2017 10-K 2020-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.